ACTG395--INDINAVIR IN COMBINATION W/ STAVUDINE & LAMIVUDINE IN HIV INF CHILDREN
ACTG395--INDINAVIR IN COMBINATION W/ STAVUDINE & LAMIVUDINE IN HIV INF CHILDREN
批准号:
6264759
负责人:
RICHARD RUTSTEIN
金额:
$0.06万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30
中文摘要
ACTG 395(和相关方案默克068)评估了indinavir(一种蛋白酶抑制剂类抗逆转录病毒)与两种核苷转录酶抑制剂(司他夫定和拉米夫定)在3-18岁艾滋病毒感染儿童中的联合应用。这项研究在1998年11月结束了新患者的累积,我们预计这项研究的治疗和数据收集将至少延长到1999年底,以允许患者在FDA审查数据期间继续使用研究药物。目前还没有初步数据。
英文摘要
ACTG 395 (and associated protocol Merck 068) evaluates the combination of indinavir (an antiretroviral of the protease inhibitor class) with two nucleoside transcriptase inhibitors (stavudine and lamivudine) in HIV infected children ages 3-18 years. This study closed to accrual of new patients in November, 1998, and we anticipate that treatment and data collection for this study will be extended until at least late 1999 to allow patients to remain on study medications while the FDA reviews the data. No preliminary data are available at this time.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STUDY OF BMS-232632 IN COMBINATION REGIMENS IN ANTIRETROVIRAL THERAPY
-
批准号:7207692
-
项目类别:
-
资助金额:$3.56万
-
财政年份:2005
-
负责人:RICHARD RUTSTEIN
-
依托单位:
PACTG 326: ALVAC HIV VACCINES AND AIDSVAX B/B IN CHILDREN BORN TO HIV MOTHERS
-
批准号:7207785
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2005
-
负责人:RICHARD RUTSTEIN
-
依托单位:
PACTG 326: ALVAC HIV VACCINES AND AIDSVAX B/B IN CHILDREN BORN TO HIV MOTHERS
-
批准号:7041890
-
项目类别:
-
资助金额:$2.12万
-
财政年份:2004
-
负责人:RICHARD RUTSTEIN
-
依托单位:
STUDY OF BMS-232632 IN COMBINATION REGIMENS IN ANTIRETROVIRAL THERAPY
-
批准号:7041819
-
项目类别:
-
资助金额:$4.2万
-
财政年份:2004
-
负责人:RICHARD RUTSTEIN
-
依托单位:
ACTG395--INDINAVIR IN COMBINATION W/ STAVUDINE & LAMIVUDINE IN HIV INF CHILDREN
-
批准号:6595453
-
项目类别:
-
资助金额:$18.67万
-
财政年份:2002
-
负责人:RICHARD RUTSTEIN
-
依托单位:
ACTG395--INDINAVIR IN COMBINATION W/ STAVUDINE & LAMIVUDINE IN HIV INF CHILDREN
-
批准号:6306320
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1999
-
负责人:RICHARD RUTSTEIN
-
依托单位:
ACTG366--4 DRUG COMBO THERAPIES BASED ON ANTIRETROVIRAL EXP IN CHILD W/ HIV
-
批准号:6306335
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1999
-
负责人:RICHARD RUTSTEIN
-
依托单位:
ACTG254--MICRONIZED ATOVAQUONE & AT/AZ AS COMPARED TO TM/ SMX
-
批准号:6264756
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:RICHARD RUTSTEIN
-
依托单位:
ACTG366--4 DRUG COMBO THERAPIES BASED ON ANTIRETROVIRAL EXP IN CHILD W/ HIV
-
批准号:6264774
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:RICHARD RUTSTEIN
-
依托单位:
ACTG300--ZDV/3TC VS DDI MONOTHERAPY VS ZDV + DDI IN HIV INFECTED CHILDREN
-
批准号:6116883
-
项目类别:
-
资助金额:$2.47万
-
财政年份:1998
-
负责人:RICHARD RUTSTEIN
-
依托单位:
ACTG254--TWO THERAPIES IN THE PREVENTION OF BACTERIAL INFECTIONS
-
批准号:6247993
-
项目类别:
-
资助金额:$2.32万
-
财政年份:1997
-
负责人:RICHARD RUTSTEIN
-
依托单位:
ACTG300--ZDV/3TC VS DDI MONOTHERAPY VS ZDV + DDI IN HIV INFECTED CHILDREN
-
批准号:6278078
-
项目类别:
-
资助金额:$2.4万
-
财政年份:1997
-
负责人:RICHARD RUTSTEIN
-
依托单位:
ACTG245 COMBINATION ANTIRETROVIRAL THERAPY IN CHILDREN/ADOL WITH ADVANCED HIV
-
批准号:6247983
-
项目类别:
-
资助金额:$2.32万
-
财政年份:1997
-
负责人:RICHARD RUTSTEIN
-
依托单位:
ACTG300--ZDV/3TC VS DDI MONOTHERAPY VS ZDV + DDI IN HIV INFECTED CHILDREN
-
批准号:6248003
-
项目类别:
-
资助金额:$2.32万
-
财政年份:1997
-
负责人:RICHARD RUTSTEIN
-
依托单位:
COMBINATION ANTIRETROVIRAL THERAPY IN ADVANCED HIV DISEASE
-
批准号:5220201
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:RICHARD RUTSTEIN
-
依托单位:--
ACTG254--MICRONIZED ATOVAQUONE & AT/AZ AS COMPARED TO TM/ SMX
-
批准号:6306317
-
项目类别:
-
资助金额:$0.06万
-
财政年份:--
-
负责人:RICHARD RUTSTEIN
-
依托单位:
海外基金